Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Treatment Algorithm for Advanced ALK-Rearranged NSCLC.
Urbanska EM, Sørensen JB, Santoni-Rugiu E. Urbanska EM, et al. J Thorac Oncol. 2020 Sep;15(9):e156-e157. doi: 10.1016/j.jtho.2020.04.039. J Thorac Oncol. 2020. PMID: 32854917 Free article. No abstract available.
Clinical outcomes of ALK+ non-small cell lung cancer in Denmark.
Hansen KH, Johansen JS, Urbanska EM, Meldgaard P, Hjorth-Hansen P, Kristiansen C, Stelmach M, Santoni-Rugiu E, Ulhøi MP, Dydensborg AB, Dünweber C, Andersen JL. Hansen KH, et al. Among authors: urbanska em. Acta Oncol. 2023 Dec;62(12):1775-1783. doi: 10.1080/0284186X.2023.2263153. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37815923
Efficacy of alectinib in lung adenocarcinoma patients with different anaplastic lymphoma kinase (ALK) rearrangements and co-existing alterations-a retrospective cohort study.
Li J, Huang K, Ji H, Qian J, Lu H, Zhang Y, Russo A, Romero A, Urbanska EM, Tabbò F, Zhao X, Chu T. Li J, et al. Among authors: urbanska em. Transl Lung Cancer Res. 2023 Dec 26;12(12):2505-2519. doi: 10.21037/tlcr-23-658. Epub 2023 Nov 22. Transl Lung Cancer Res. 2023. PMID: 38205204 Free PMC article.
Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery.
Urbanska EM, Santoni-Rugiu E, Melchior LC, Carlsen JF, Sørensen JB. Urbanska EM, et al. Clin Lung Cancer. 2021 Jul;22(4):e528-e532. doi: 10.1016/j.cllc.2020.04.012. Epub 2020 Jun 4. Clin Lung Cancer. 2021. PMID: 32651064 Free article. No abstract available.